Edwards Lifesciences (EW) Treasury Shares (2009 - 2026)

Edwards Lifesciences has reported Treasury Shares for 18 years, with the latest figure at $7.7 billion in Q2 2026.

• On a quarterly basis, Treasury Shares rose 18.77% year-over-year to $7.7 billion in Q2 2026; TTM through Jun 2026 was $7.7 billion, a 18.77% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 14.52% from the prior year.
• Treasury Shares was $7.7 billion for Q2 2026 at Edwards Lifesciences, up from $7.5 billion in the prior quarter.
• The five-year high for Treasury Shares was $85.1 million in Q2 2026, with the low at $21.5 million in Q1 2022.
• Average Treasury Shares over 5 years is $54.5 million, with a median of $50.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares surged 71.46% in 2022, then gained 14.37% in 2024.
• Over 5 years, Treasury Shares stood at $4.1 billion in 2022, then increased by 21.25% to $5.0 billion in 2023, then advanced by 23.24% to $6.2 billion in 2024, then gained by 14.52% to $7.1 billion in 2025, then climbed by 8.13% to $7.7 billion in 2026.
• The last three Treasury Shares figures came in at $7.7 billion (Q2 2026), $7.5 billion (Q1 2026), and $7.1 billion (Q4 2025), per Business Quant data.